Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-6-3
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0340-6245
pubmed:author
pubmed:issnType
Print
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1170-1
pubmed:meshHeading
pubmed-meshheading:19492163-Adult, pubmed-meshheading:19492163-Aged, pubmed-meshheading:19492163-Aged, 80 and over, pubmed-meshheading:19492163-Antineoplastic Agents, pubmed-meshheading:19492163-Blood Coagulation Tests, pubmed-meshheading:19492163-Cross-Sectional Studies, pubmed-meshheading:19492163-Female, pubmed-meshheading:19492163-Follow-Up Studies, pubmed-meshheading:19492163-Hemorrhage, pubmed-meshheading:19492163-Humans, pubmed-meshheading:19492163-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:19492163-Male, pubmed-meshheading:19492163-Middle Aged, pubmed-meshheading:19492163-Philadelphia Chromosome, pubmed-meshheading:19492163-Piperazines, pubmed-meshheading:19492163-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:19492163-Pyrimidines, pubmed-meshheading:19492163-Thrombocytopenia, pubmed-meshheading:19492163-Treatment Outcome, pubmed-meshheading:19492163-Withholding Treatment, pubmed-meshheading:19492163-alpha-2-Antiplasmin
pubmed:year
2009
pubmed:articleTitle
Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer.
pubmed:publicationType
Letter